BRIMONIDINE TARTRATE

N/A

Manufactured by Sandoz Inc

28,834 FDA adverse event reports analyzed

Last updated: 2026-04-14

About BRIMONIDINE TARTRATE

BRIMONIDINE TARTRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Sandoz Inc. The most commonly reported adverse reactions for BRIMONIDINE TARTRATE include TREATMENT FAILURE, DRUG INEFFECTIVE, ERYTHEMA, EYE IRRITATION, OCULAR HYPERAEMIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BRIMONIDINE TARTRATE.

Top Adverse Reactions

TREATMENT FAILURE2,862 reports
DRUG INEFFECTIVE1,241 reports
ERYTHEMA746 reports
EYE IRRITATION732 reports
OCULAR HYPERAEMIA726 reports
EYE PAIN701 reports
HYPERSENSITIVITY693 reports
FATIGUE676 reports
OFF LABEL USE657 reports
INTRAOCULAR PRESSURE INCREASED601 reports
VISION BLURRED597 reports
DIZZINESS530 reports
HEADACHE514 reports
CONDITION AGGRAVATED478 reports
DIARRHOEA451 reports
DYSPNOEA417 reports
NAUSEA398 reports
DEATH394 reports
FALL385 reports
VISUAL IMPAIRMENT375 reports
GLAUCOMA358 reports
ASTHENIA355 reports
PAIN334 reports
PRURITUS332 reports
EYE PRURITUS324 reports
DRUG HYPERSENSITIVITY321 reports
RASH313 reports
FLUSHING305 reports
PRODUCT DOSE OMISSION ISSUE293 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION284 reports
DRY EYE279 reports
PNEUMONIA278 reports
MALAISE267 reports
COUGH259 reports
SOMNOLENCE254 reports
CATARACT235 reports
ARTHRALGIA234 reports
PAIN IN EXTREMITY218 reports
VOMITING218 reports
EYE SWELLING211 reports
HYPOTENSION203 reports
VISUAL ACUITY REDUCED202 reports
LACRIMATION INCREASED201 reports
URINARY TRACT INFECTION200 reports
WEIGHT DECREASED198 reports
DRY MOUTH195 reports
INCORRECT DOSE ADMINISTERED194 reports
CONSTIPATION191 reports
DECREASED APPETITE190 reports
HYPERTENSION189 reports
SKIN BURNING SENSATION189 reports
ACUTE KIDNEY INJURY185 reports
ROSACEA182 reports
INSOMNIA180 reports
PYREXIA180 reports
CHRONIC KIDNEY DISEASE171 reports
BLOOD PRESSURE INCREASED170 reports
ANAEMIA168 reports
FEELING HOT168 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION167 reports
PRODUCT USE ISSUE167 reports
BACK PAIN165 reports
EYE DISORDER160 reports
CONFUSIONAL STATE159 reports
PERIPHERAL SWELLING159 reports
GAIT DISTURBANCE153 reports
ABDOMINAL PAIN150 reports
RENAL FAILURE145 reports
ATRIAL FIBRILLATION142 reports
BLINDNESS142 reports
REBOUND EFFECT142 reports
DEPRESSION140 reports
PRODUCT QUALITY ISSUE139 reports
FEELING ABNORMAL138 reports
PRODUCT STORAGE ERROR138 reports
ANXIETY137 reports
DRUG INTOLERANCE136 reports
PRODUCT CONTAINER ISSUE133 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS132 reports
PHOTOPHOBIA131 reports
FOREIGN BODY SENSATION IN EYES128 reports
ACCIDENTAL EXPOSURE TO PRODUCT127 reports
PRODUCT USE IN UNAPPROVED INDICATION124 reports
WEIGHT INCREASED123 reports
ABDOMINAL PAIN UPPER122 reports
EYE DISCHARGE122 reports
BURNING SENSATION121 reports
DRY SKIN121 reports
ALOPECIA119 reports
BALANCE DISORDER119 reports
DRUG DOSE OMISSION119 reports
PARAESTHESIA119 reports
CONJUNCTIVITIS118 reports
BLINDNESS UNILATERAL116 reports
SWELLING FACE113 reports
LOSS OF CONSCIOUSNESS112 reports
CHEST PAIN111 reports
BRADYCARDIA108 reports
NASOPHARYNGITIS108 reports
BLOOD GLUCOSE INCREASED107 reports

Report Outcomes

Out of 17,080 classified reports for BRIMONIDINE TARTRATE:

Serious 42.4%Non-Serious 57.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female9,634 (59.6%)
Male6,495 (40.1%)
Unknown49 (0.3%)

Reports by Age

Age 75286 reports
Age 70278 reports
Age 74262 reports
Age 78259 reports
Age 73250 reports
Age 76245 reports
Age 72238 reports
Age 77237 reports
Age 71235 reports
Age 69225 reports
Age 68220 reports
Age 82215 reports
Age 66206 reports
Age 79206 reports
Age 81205 reports
Age 83190 reports
Age 67188 reports
Age 80188 reports
Age 64180 reports
Age 85179 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with BRIMONIDINE TARTRATE?

This profile reflects 28,834 FDA FAERS reports that mention BRIMONIDINE TARTRATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for BRIMONIDINE TARTRATE?

Frequently reported terms in FAERS include TREATMENT FAILURE, DRUG INEFFECTIVE, ERYTHEMA, EYE IRRITATION, OCULAR HYPERAEMIA, EYE PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures BRIMONIDINE TARTRATE?

Labeling and FAERS entries often list Sandoz Inc in connection with BRIMONIDINE TARTRATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.